Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: In-clinic evaluation of safety and efficacy

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 27, Issue 1, 2006, Pages 31-41

  Heiman, Julia R ^a,f   Gittelman, Marc ^b   Costabile, Raymond ^c   Guay, Andre ^d   Friedman, Alice ^a   Heard Davison, Amy ^a   Peterson, Craig ^e   Dietrich, John ^e   Stephens, Darby ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b South Florida Medical Research   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e Menlo Park and VIVUS   (United States)

^f INDIANA UNIVERSITY   (United States)

Author keywords

Female sexual arousal disorder; Randomized trial; Topical alprostadil

Indexed keywords

PLACEBO; PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPEREMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL SATISFACTION; VISUAL STIMULATION; DRUG ADMINISTRATION; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOSEXUAL DISORDER; SATISFACTION; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ALPROSTADIL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; PERSONAL SATISFACTION; PROSPECTIVE STUDIES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TIME FACTORS; VASODILATOR AGENTS;

EID: 33646789457     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.1080/01674820500237973     Document Type: Article

References (21)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-544.
2. Bancroft J, Loftus J, Long JS. Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Beh 2003;32:193-208.
3. Heiman J, Meston M. Empirically validated treatment for sexual dysfunction. Ann Rev Sex Res 1997;8:148-194.
4. American Psychiatric Association. DSM-IV: Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
5. World Health Organization. ICD-10: International statistical classification of diseases and related health problems. Geneva: World Health Organization, 1992.
6. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 2003;24:221-229.
7. Heiman JR. Psychophysiological models of female sexual response. Int J Impot Res 1998;10(Suppl. 2):S94-S97.
8. Laan E, Everaerd W, Evers A. Assessment of female sexual arousal: response specificity and construct validity. Psychophysiology 1995;32:376.
9. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral insufficiency syndromes. Int J Impot Res 1998;10(Suppl. 2):S84-S90.
10. Levin RL. Sex and the human female reproductive tract - what really happens during and after coitus. Int J Impot Res 1998;10(Suppl. 1):S14-S21.
11. Levin, RL. The mechanisms of human female sexual arousal. Ann Rev of Sex Res 1992;3:1-48.
12. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-229.
13. Chang CC, Lin SN, Chen FS, et al. 15-Hydroxyprostaglandin dehydrogenase activity in the lower genitourinary tract. A preliminary report. Br J Urol 1991;68:579-581.
14. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Urethral System for Erection (MUSE) Study Group. N Engl J Med 1997;336(1):1-7.
15. Rosen RC, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191.
16. Derogatis LR, Rosen RC, Leiblum S, et al. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317.
17. Morokoff P, Heiman J. Effects of erotic stimuli on sexually functional and dysfunctional women: Multiple measures before and after sex therapy. Behav Res Ther 1980;18:127-137.
18. Heiman J. Female sexual response patterns: Interactions of physiological, affective, and contextual cues. Arch Gen Psychiatry 1980;37:1311-1316.
19. Hackbert L, Heiman JR. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Women's Health Gender-Based Med 2002;11:155-162.
20. Brody S, Laan E, van Lunsen RH. Concordance between women's physiological and subjective sexual arousal is associated with consistency of orgasm during intercourse but not other sexual behavior. J Sex Marital Ther 2003;29:15-23.
21. Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999;20:109-117.